Characterization of population specific immune responses in support of HIV vaccine trials

Primary Objective: To characterize assays and methods that can be used to evaluate vaccines/drugs, assess factors that may alter immune responses, characterize population specific baseline immune responses, and assess cryopreservation of Immune and/or Mononuclear cells (MNCs) in preparation for clinical trials